PDS Biotechnology (PDSB)
(Real Time Quote from BATS)
$3.08 USD
-0.06 (-1.91%)
Updated Sep 24, 2024 12:00 PM ET
2-Buy of 5 2
D Value B Growth F Momentum D VGM
Cash flow Statements
Fiscal Year End for PDS Biotechnology Corporation falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -42.94 | -40.85 | -16.92 | -14.85 | -7.00 |
Depreciation/Amortization & Depletion | 0.71 | 0.23 | 0.01 | 0.02 | 0.10 |
Net Change from Assets/Liabilities | -0.20 | 4.47 | 0.08 | 1.57 | -3.06 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 8.80 | 10.44 | 4.35 | 0.11 | -8.11 |
Net Cash From Operating Activities | -33.64 | -25.71 | -12.49 | -13.15 | -18.07 |
Property & Equipment | 0.00 | 0.00 | 0.00 | 0.00 | 0.28 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | 29.11 |
Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 29.38 |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 16.44 | 10.01 | 48.89 | 29.83 | 0.75 |
Issuance (Repayment) of Debt | -0.06 | 25.00 | 0.00 | 0.00 | 0.00 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | 0.00 | -0.72 | 0.00 | 0.00 | 0.00 |
Net Cash from Financing Activities | 16.38 | 34.29 | 48.89 | 29.83 | 0.75 |
Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | -17.26 | 8.58 | 36.40 | 16.68 | 12.06 |
Cash at Beginning of Period | 73.82 | 65.24 | 28.84 | 12.16 | 0.10 |
Cash at End of Period | 56.56 | 73.82 | 65.24 | 28.84 | 12.16 |
Diluted Net EPS | -1.39 | -1.43 | -0.66 | -0.89 | -1.44 |
Fiscal Year End for PDS Biotechnology Corporation falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -18.93 | -10.60 | -42.94 | -32.04 | -21.19 |
Depreciation/Amortization & Depletion | 0.58 | 0.28 | 0.71 | 0.43 | 0.26 |
Net Change from Assets/Liabilities | -4.14 | -1.25 | -0.20 | -0.60 | -1.64 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 3.69 | 1.63 | 8.80 | 7.03 | 4.57 |
Net Cash From Operating Activities | -18.80 | -9.94 | -33.64 | -25.18 | -18.00 |
Property & Equipment | -0.03 | 0.00 | 0.00 | 0.00 | 0.00 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | -0.03 | 0.00 | 0.00 | 0.00 | 0.00 |
Uses of Funds
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 20.03 | 20.03 | 16.44 | 5.66 | 4.84 |
Issuance (Repayment) of Debt | -0.03 | -0.01 | -0.06 | -0.05 | -0.03 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Financing Activities | 20.00 | 20.01 | 16.38 | 5.61 | 4.81 |
Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | 1.17 | 10.07 | -17.26 | -19.57 | -13.20 |
Cash at Beginning of Period | 56.56 | 56.56 | 73.82 | 73.82 | 73.82 |
Cash at End of Period | 57.73 | 66.63 | 56.56 | 54.25 | 60.62 |
Diluted Net EPS | -0.23 | -0.30 | -0.35 | -0.35 | -0.37 |